Our collaborative team have succeeded in demonstrating in human trial that oral administration of konjac-derived ceramides attenuates amyloid-ß accumulation in brains. This result is expected to contribute to preventive method development for Alzheimer’s disease.
Hokkaido University Press Release (in Japanese)